Corcept Therapeutics IncorporatedCORTNASDAQ
Loading
EV to Sales: Discounted ValuationCompressed
Percentile Rank14
3Y CAGR-4.2%
5Y CAGR-11.2%
Year-over-Year Change
Enterprise value to sales ratio
3Y CAGR
-4.2%/yr
vs -2.8%/yr prior
5Y CAGR
-11.2%/yr
Recent acceleration
Acceleration
-1.5pp
Decelerating
Percentile
P14
Within normal range
vs 5Y Ago
0.6x
Contraction
Streak
1 yr
Consecutive declineCompressed
| Period | Value | YoY Change |
|---|---|---|
| 2025 | 4.60 | -38.9% |
| 2024 | 7.53 | +12.5% |
| 2023 | 6.69 | +27.8% |
| 2022 | 5.23 | -13.4% |
| 2021 | 6.05 | -27.4% |
| 2020 | 8.32 | +88.2% |
| 2019 | 4.42 | -24.5% |
| 2018 | 5.86 | -52.1% |
| 2017 | 12.23 | +29.8% |
| 2016 | 9.42 | - |